Lipid-based vectors for siRNA delivery

References

• Adrian JE, Morselt HW, Süss R, Barnert S, Kok JW, Asgeirsdóttir SA, Ruiters MH, Molema G, Kamps JA. (2010). Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells. J Control Release, 144, 341–349.
   PubMed Web of Science ®Google Scholar
• Ahmad A, Evans HM, Ewert K, George CX, Samuel CE, Safinya CR. (2005). New multivalent cationic lipids reveal bell curve for transfection efficiency versus membrane charge density: lipid-DNA complexes for gene delivery. J Gene Med, 7, 739–748.
   PubMed Web of Science ®Google Scholar
• Akinc A, Goldberg M, Qin J, Dorkin JR, Gamba-Vitalo C, Maier M, Jayaprakash KN, Jayaraman M, Rajeev KG, Manoharan M, Koteliansky V, Röhl I, Leshchiner ES, Langer R, Anderson DG. (2009). Development of Lipidoid–siRNA Formulations for Systemic Delivery to the Liver. Mol Ther, 17, 872–879.
   PubMed Web of Science ®Google Scholar
• Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, Busini V, Hossain N, Bacallado SA, Nguyen DN, Fuller J, Alvarez R, Borodovsky A, Borland T, Constien R, de Fougerolles A, Dorkin JR, Narayanannair Jayaprakash K, Jayaraman M, John M, Koteliansky V, Manoharan M, Nechev L, Qin J, Racie T, Raitcheva D, Rajeev KG, Sah DW, Soutschek J, Toudjarska I, Vornlocher HP, Zimmermann TS, Langer R, Anderson DG. (2008). A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol, 26, 561–569.
   PubMed Web of Science ®Google Scholar
• Arpicco S, Canevari S, Ceruti M, Galmozzi E, Rocco F, Cattel, L. (2004). Synthesis characterization and transfection activity of new saturated and unsaturated cationic lipids. IL FARMACO, 59, 869–878.
   PubMedGoogle Scholar
• Barreau C, Dutertre S, Paillard L, Osborne HB. (2006). Liposome-mediated RNA transfection should be used with caution. RNA, 12, 1790–1793.
   PubMed Web of Science ®Google Scholar
• Beale G, Hollins AJ, Benboubetra M, Sohail M, Fox SP, Benter I, Akhtar S. (2003). Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system. J Drug Target, 11, 449–456.
   PubMed Web of Science ®Google Scholar
• Bianco A, Bonadies F, Napolitano R, Ortaggi G. (2005). A simple approach to DC-cholesterol, its analogues and vitamin D-based cationic lipids for gene therapy. Lett Org Chem, 2, 79–82.
   Web of Science ®Google Scholar
• Bouxsein NF, McAllister CS, Ewert KK, Samuel CE, Safinya CR. (2007). Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA. Biochemistry, 46, 4785–4792.
   PubMed Web of Science ®Google Scholar
• Bouxsein NF, McAllister CS, Ewert KK, Samuel CE, Safinya CR. (2007). Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA. Biochemistry, 46, 4785–4792.
   PubMed Web of Science ®Google Scholar
• Ceballos C, Prata CA, Giorgio S, Garzino F, Payet D, Barthélémy P, Grinstaff MW, Camplo M. (2009). Cationic nucleoside lipids based on a 3-nitropyrrole universal base for siRNA delivery. Bioconjug Chem, 20, 193–196.
   PubMed Web of Science ®Google Scholar
• Cevc G, Richardsen H. (1999). Lipid vesicles and membrane fusion. Adv Drug Deliv Rev, 38, 207–232.
   PubMed Web of Science ®Google Scholar
• Chabaud P, Camplo M, Payet D, Serin G, Moreau L, Barthélémy P, Grinstaff MW. (2006). Cationic nucleoside lipids for gene delivery. Bioconjug Chem, 17, 466–472.
   PubMed Web of Science ®Google Scholar
• Chan CL, Majzoub R, Shirazi RS, Liang KS, Ewert KK, Safinya CR. (2012a). pH-Sensitive pegylated cationic lipid-DNA complexes for gene delivery: transfection efficiency and live cell imaging studies. Biophys J, 102, 501–502a.
   Google Scholar
• Chan CL, Majzoub RN, Shirazi RS, Ewert KK, Chen YJ, Liang KS, Safinya CR. (2012). Endosomal escape and transfection efficiency of PEGylated cationic liposome-DNA complexes prepared with an acid-labile PEG-lipid. Biomaterials, 33, 4928–4935.
   PubMed Web of Science ®Google Scholar
• Chen Y, Bathula SR, Li J, Huang L. (2010). Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer. J Biol Chem, 285, 22639–22650.
   PubMed Web of Science ®Google Scholar
• Chen Y, Bathula SR, Yang Q, Huang L. (2010). Targeted nanoparticles deliver siRNA to melanoma. J Invest Dermatol, 130, 2790–2798.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhu X, Zhang X, Liu B, Huang L. (2010). Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol Ther, 18, 1650–1656.
   PubMed Web of Science ®Google Scholar
• Chen Y, Sen J, Bathula SR, Yang Q, Fittipaldi R, Huang L. (2009). Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells. Mol Pharm, 6, 696–705.
   PubMed Web of Science ®Google Scholar
• Chono S, Li SD, Conwell CC, Huang L. (2008). An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor. J Control Release, 131, 64–69.
   PubMed Web of Science ®Google Scholar
• de Wolf HK, de Raad M, Snel C, van Steenbergen MJ, Fens MH, Storm G, Hennink WE. (2007). Biodegradable poly(2-dimethylamino ethylamino)phosphazene for in vivo gene delivery to tumor cells. Effect of polymer molecular weight. Pharm Res, 24, 1572–1580.
   PubMed Web of Science ®Google Scholar
• Elouahabi A, Ruysschaert JM. (2005). Formation and intracellular trafficking of lipoplexes and polyplexes. Mol Ther, 11, 336–347.
   PubMed Web of Science ®Google Scholar
• Ewert K, Ahmad A, Evans HM, Schmidt HW, Safinya CR. (2002). Efficient synthesis and cell-transfection properties of a new multivalent cationic lipid for nonviral gene delivery. J Med Chem, 45, 5023–5029.
   PubMed Web of Science ®Google Scholar
• Farhood H, Bottega R, Epand RM, Huang L. (1992). Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity. Biochim Biophys Acta, 1111, 239–246.
   PubMed Web of Science ®Google Scholar
• Farhood H, Serbina N, Huang L. (1995). The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta, 1235, 289–295.
   PubMed Web of Science ®Google Scholar
• Felgner PL, Gadek TR, Holm M, Roman R, Chan HS, Wenz M, Northrop JP, Ringold GM, Danielsen M. (1987). Lipofection: a highly efficient,lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA, 84, 7413–7417.
   PubMed Web of Science ®Google Scholar
• Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806–811.
   PubMed Web of Science ®Google Scholar
• Flynn MA, Casey DG, Todryk SM, Mahon BP. (2004). Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo. J Inflamm (Lond), 1, 4.
   PubMedGoogle Scholar
• Foged C, Nielsen HM, Frokjaer S. (2007). Liposomes for phospholipase A2 triggered siRNA release: preparation and in vitro test. Int J Pharm, 331, 160–166.
   PubMed Web of Science ®Google Scholar
• Foged C. (2012). siRNA delivery with lipid-based systems: promises and pitfalls. Curr Top Med Chem, 12, 97–107.
   PubMed Web of Science ®Google Scholar
• Gao K, Huang L. (2009). Nonviral methods for siRNA delivery. Mol Pharm, 6, 651–658.
   PubMed Web of Science ®Google Scholar
• Gao X, Huang L. (1996). Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry, 35, 1027–1036.
   PubMed Web of Science ®Google Scholar
• Geisbert TW, Lee AC, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC, de Jong S, Tavakoli I, Judge A, Hensley LE, Maclachlan I. (2010). Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet, 375, 1896–1905.
   PubMed Web of Science ®Google Scholar
• Gilmore IR, Fox SP, Hollins AJ, Sohail M, Akhtar S. (2004). The design and exogenous delivery of siRNA for post-transcriptional gene silencing. J Drug Target, 12, 315–340.
   PubMed Web of Science ®Google Scholar
• Guo J, Bourre L, Soden DM, O’Sullivan GC, O’Driscoll C. (2011). Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics? Biotechnol Adv, 29, 402–417.
   PubMed Web of Science ®Google Scholar
• Heyes J, Palmer L, Bremner K, MacLachlan I. (2005). Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. J Control Release, 107, 276–287.
   PubMed Web of Science ®Google Scholar
• Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, Noronha A, Manoharan M, Akira S, de Fougerolles A, Endres S, Hartmann G. (2005). Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med, 11, 263–270.
   PubMed Web of Science ®Google Scholar
• Huang YH, Bao Y, Peng W, Goldberg M, Love K, Bumcrot DA, Cole G, Langer R, Anderson DG, Sawicki JA. (2009). Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis. Proc Natl Acad Sci USA, 106, 3426–3430.
   PubMed Web of Science ®Google Scholar
• Jana S, Chakraborty C, Nandi S, Deb JK. (2004). RNA interference: potential therapeutic targets. Appl Microbiol Biotechnol, 65, 649–657.
   PubMed Web of Science ®Google Scholar
• Jiang S, Zhang Y. (2010). Upconversion nanoparticle-based FRET system for study of siRNA in live cells. Langmuir, 26, 6689–6694.
   PubMed Web of Science ®Google Scholar
• John M, Constien R, Akinc A, Goldberg M, Moon YA, Spranger M, Hadwiger P, Soutschek J, Vornlocher HP, Manoharan M, Stoffel M, Langer R, Anderson DG, Horton JD, Koteliansky V, Bumcrot D. (2007). Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway. Nature, 449, 745–747.
   PubMed Web of Science ®Google Scholar
• Judge AD, Sood V, Shaw JR, Fang D, McClintock K, MacLachlan I. (2005). Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol, 23, 457–462.
   PubMed Web of Science ®Google Scholar
• Juliano R, Alam MR, Dixit V, Kang H. (2008). Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res, 36, 4158–4171.
   PubMed Web of Science ®Google Scholar
• Karagiannis TC, El-Osta A. (2005). RNA interference and potential therapeutic applications of short interfering RNAs. Cancer Gene Ther, 12, 787–795.
   PubMed Web of Science ®Google Scholar
• Kemphues KJ, Guo S. (1995). par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell, 81, 611–620.
   PubMed Web of Science ®Google Scholar
• Khan A, Benboubetra M, Sayyed PZ, Ng KW, Fox S, Beck G, Benter IF, Akhtar S. (2004). Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies. J Drug Target, 12, 393–404.
   PubMed Web of Science ®Google Scholar
• Khoury M, Louis-Plence P, Escriou V, Noel D, Largeau C, Cantos C, Scherman D, Jorgensen C, Apparailly F. (2006). Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor α in experimental arthritis. Arthritis Rheum, 54, 1867–1877.
   PubMed Web of Science ®Google Scholar
• Li CX, Parker A, Menocal E, Xiang S, Borodyansky L, Fruehauf JH. (2006). Delivery of RNA interference. Cell Cycle, 5, 2103–2109.
   PubMed Web of Science ®Google Scholar
• Li J, Chen YC, Tseng YC, Mozumdar S, Huang L. (2010). Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. J Control Release, 142, 416–421.
   PubMed Web of Science ®Google Scholar
• Li J, Yang Y, Huang L. (2012). Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor. J Control Release, 158, 108–114.
   PubMed Web of Science ®Google Scholar
• Li S, Huang L. (1997). In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes. Gene Ther, 4, 891–900.
   PubMed Web of Science ®Google Scholar
• Li SD, Chono S, Huang L. (2008). Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA. Mol Ther, 16, 942–946.
   PubMed Web of Science ®Google Scholar
• Li SD, Chono S, Huang L. (2008). Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles. J Control Release, 126, 77–84.
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L. (2006). Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. Mol Pharm, 3, 579–588.
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L. (2006). Surface-modified LPD nanoparticles for tumor targeting. Ann N Y Acad Sci, 1082, 1–8.
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L. (2009). Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. Biochim Biophys Acta, 1788, 2259–2266.
   PubMed Web of Science ®Google Scholar
• Liu D, Hu J, Qiao W, Li Z, Zhang S, Cheng L. (2005). Synthesis of carbamate-linked lipids for gene delivery. Bioorg Med Chem Lett, 15, 3147–3150.
   PubMed Web of Science ®Google Scholar
• Liu D, Hu J, Qiao W, Li Z, Zhan S, Cheng L. (2005). Synthesis and characterization of a series of carbamate-linked cationic lipids for gene delivery. Lipids, 40, 839–848.
   PubMed Web of Science ®Google Scholar
• Liu D, Qiao W, Li Z, Chen Y, Cui X, Li K, Yu L, Yan K, Zhu L, Guo Y, Cheng L. (2008). Structure-function relationship research of glycerol backbone-based cationic lipids for gene delivery. Chem Biol Drug Des, 71, 336–344.
   PubMed Web of Science ®Google Scholar
• Liu F, Huang L. (2002). Development of non-viral vectors for systemic gene delivery. J Control Release, 78, 259–266.
   PubMed Web of Science ®Google Scholar
• Lorenz C, Hadwiger P, John M, Vornlocher HP, Unverzagt C. (2004). Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells. Bioorg Med Chem Lett, 14, 4975–4977.
   PubMed Web of Science ®Google Scholar
• Love KT, Mahon KP, Levins CG, Whitehead KA, Querbes W, Dorkin JR, Qin J, Cantley W, Qin LL, Racie T, Frank-Kamenetsky M, Yip KN, Alvarez R, Sah DW, de Fougerolles A, Fitzgerald K, Koteliansky V, Akinc A, Langer R, Anderson DG. (2010). Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci USA, 107, 1864–1869.
   PubMed Web of Science ®Google Scholar
• Lv H, Zhang S, Wang B, Cui S, Yan J. (2006). Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release, 114, 100–109.
   PubMed Web of Science ®Google Scholar
• Ma B, Zhang S, Jiang H, Zhao B, Lv H. (2007). Lipoplex morphologies and their influences on transfection efficiency in gene delivery. J Control Release, 123, 184–194.
   PubMed Web of Science ®Google Scholar
• Mahon KP, Love KT, Whitehead KA, Qin J, Akinc A, Leshchiner E, Leshchiner I, Langer R, Anderson DG. (2010). Combinatorial approach to determine functional group effects on lipidoid-mediated siRNA delivery. Bioconjug Chem, 21, 1448–1454.
   PubMed Web of Science ®Google Scholar
• Malone RW, Felgner PL, Verma IM. (1989). Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci USA, 86, 6077–6081.
   PubMed Web of Science ®Google Scholar
• Mamot C, Drummond DC, Noble CO, Kallab V, Guo Z, Hong K, Kirpotin DB, Park JW. (2005). Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer Res, 65, 11631–11638.
   PubMed Web of Science ®Google Scholar
• Mével M, Kamaly N, Carmona S, Oliver MH, Jorgensen MR, Crowther C, Salazar FH, Marion PL, Fujino M, Natori Y, Thanou M, Arbuthnot P, Yaouanc JJ, Jaffrès PA, Miller AD. (2010). DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA. J Control Release, 143, 222–232.
   PubMed Web of Science ®Google Scholar
• Midoux P, Pichon C, Yaouanc JJ, Jaffrès PA. (2009). Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br J Pharmacol, 157, 166–178.
   PubMed Web of Science ®Google Scholar
• Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit JP. (2008). Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials, 29, 3477–3496.
   PubMed Web of Science ®Google Scholar
• Morrissey DV, Lockridge JA, Shaw L, Blanchard K, Jensen K, Breen W, Hartsough K, Machemer L, Radka S, Jadhav V, Vaish N, Zinnen S, Vargeese C, Bowman K, Shaffer CS, Jeffs LB, Judge A, MacLachlan I, Polisky B. (2005). Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol, 23, 1002–1007.
   PubMed Web of Science ®Google Scholar
• Oh YK, Park TG. (2009). siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev, 61, 850–862.
   PubMed Web of Science ®Google Scholar
• Omidi Y, Hollins AJ, Benboubetra M, Drayton R, Benter IF, Akhtar S. (2003). Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells. J Drug Target, 11, 311–323.
   PubMed Web of Science ®Google Scholar
• Ozpolat B, Sood AK, Lopez-Berestein G. (2010). Nanomedicine based approaches for the delivery of siRNA in cancer. J Intern Med, 267, 44–53.
   PubMed Web of Science ®Google Scholar
• Pan X, Thompson R, Meng X, Wu D, Xu L. (2011). Tumor-targeted RNA-interference: functional non-viral nanovectors. Am J Cancer Res, 1, 25–42.
   Web of Science ®Google Scholar
• Park K. (2010). Systemic siRNA delivery using biocompatible calcium phosphate nanoparticles. J Control Release, 142, 295.
   PubMed Web of Science ®Google Scholar
• Perkel JM. (2009). RNAi therapeutics: a two-year update. Science, 326, 454–456.
   Web of Science ®Google Scholar
• Pirollo KF, Rait A, Zhou Q, Hwang SH, Dagata JA, Zon G, Hogrefe RI, Palchik G, Chang EH. (2007). Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system. Cancer Res, 67, 2938–2943.
   PubMed Web of Science ®Google Scholar
• Romøren K, Thu BJ, Bols NC, Evensen Ø. (2004). Transfection efficiency and cytotoxicity of cationic liposomes in salmonid cell lines of hepatocyte and macrophage origin. Biochim Biophys Acta, 1663, 127–134.
   PubMed Web of Science ®Google Scholar
• Rossin R, Pan D, Qi K, Turner JL, Sun X, Wooley KL, Welch MJ. (2005). 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. J Nucl Med, 46, 1210–1218.
   PubMed Web of Science ®Google Scholar
• Sato A, Takagi M, Shimamoto A, Kawakami S, Hashida M. (2007). Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice. Biomaterials, 28, 1434–1442.
   PubMed Web of Science ®Google Scholar
• Scales CW, Huang F, Li N, Vasilieva YA, Ray J, Convertine AJ, McCormick CL. (2006). Corona-stabilized interpolyelectrolyte complexes of siRNA with non-immunogenic, hydrophilic/cationic block copolymers prepared by aqueous RAFT polymerization. Macromolecules, 39, 6871–6881.
   Web of Science ®Google Scholar
• Schroeder A, Levins CG, Cortez C, Langer R, Anderson DG. (2010). Lipid-based nanotherapeutics for siRNA delivery. J Intern Med, 267, 9–21.
   PubMed Web of Science ®Google Scholar
• Semple SC, Akinc A, Chen J, Sandhu AP, Mui BL, Cho CK, Sah DW, Stebbing D, Crosley EJ, Yaworski E, Hafez IM, Dorkin JR, Qin J, Lam K, Rajeev KG, Wong KF, Jeffs LB, Nechev L, Eisenhardt ML, Jayaraman M, Kazem M, Maier MA, Srinivasulu M, Weinstein MJ, Chen Q, Alvarez R, Barros SA, De S, Klimuk SK, Borland T, Kosovrasti V, Cantley WL, Tam YK, Manoharan M, Ciufolini MA, Tracy MA, de Fougerolles A, MacLachlan I, Cullis PR, Madden TD, Hope MJ. (2010). Rational design of cationic lipids for siRNA delivery. Nat Biotechnol, 28, 172–176.
   PubMed Web of Science ®Google Scholar
• Sheng R, Luo T, Zhu Y, Li H, Sun J, Chen S, Sun W, Cao A. (2011). The intracellular plasmid DNA localization of cationic reducible cholesterol-disulfide lipids. Biomaterials, 32, 3507–3519.
   PubMed Web of Science ®Google Scholar
• Shirazi RS, Ewert KK, Leal C, Majzoub RN, Bouxsein NF, Safinya CR. (2011). Synthesis and characterization of degradable multivalent cationic lipids with disulfide-bond spacers for gene delivery. Biochim Biophys Acta, 1808, 2156–2166.
   PubMed Web of Science ®Google Scholar
• Sioud M, Sørensen DR. (2003). Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem Biophys Res Commun, 312, 1220–1225.
   PubMed Web of Science ®Google Scholar
• Sorgi FL, Bhattacharya S, Huang L. (1997). Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther, 4, 961–968.
   PubMed Web of Science ®Google Scholar
• Sparks J, Slobodkin G, Matar M, Congo R, Ulkoski D, Rea-Ramsey A, Pence C, Rice J, McClure D, Polach KJ, Brunhoeber E, Wilkinson L, Wallace K, Anwer K, Fewell JG. (2012). Versatile cationic lipids for siRNA delivery. J Control Release, 158, 269–276.
   PubMed Web of Science ®Google Scholar
• Spelios M, Nedd S, Matsunaga N, Savva M. (2007). Effect of spacer attachment sites and pH-sensitive headgroup expansion on cationic lipid-mediated gene delivery of three novel myristoyl derivatives. Biophys Chem, 129, 137–147.
   PubMed Web of Science ®Google Scholar
• Tan SJ, Kiatwuthinon P, Roh YH, Kahn JS, Luo D. (2011). Engineering Nanocarriers for siRNA Delivery. Small, 7, 841–856.
   PubMed Web of Science ®Google Scholar
• Tao W, Davide JP, Cai M, Zhang GJ, South VJ, Matter A, Ng B, Zhang Y, Sepp-Lorenzino L. (2010). Noninvasive imaging of lipid nanoparticle-mediated systemic delivery of small-interfering RNA to the liver. Mol Ther, 18, 1657–1666.
   PubMed Web of Science ®Google Scholar
• Verma UN, Surabhi RM, Schmaltieg A, Becerra C, Gaynor RB. (2003). RNAs directed against betacatenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res, 9, 1291–1300.
   PubMed Web of Science ®Google Scholar
• Sørensen DR, Leirdal M, Sioud M. (2003). Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol, 327, 761–766.
   PubMed Web of Science ®Google Scholar
• Wagner E, Cotten M, Foisner R, Birnstiel ML. (1991). Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. Proc Natl Acad Sci USA, 88, 4255–4259.
   PubMed Web of Science ®Google Scholar
• Wang AZ, Langer R, Farokhzad OC. (2012). Nanoparticle delivery of cancer drugs. Annu Rev Med, 63, 185–198.
   PubMed Web of Science ®Google Scholar
• Whitehead KA, Langer R, Anderson DG. (2009). Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov, 8, 129–138.
   PubMed Web of Science ®Google Scholar
• Whitehead KA, Sahay G, Li GZ, Love KT, Alabi CA, Ma M, Zurenko C, Querbes W, Langer RS, Anderson DG. (2011). Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery. Mol Ther, 19, 1688–1694.
   PubMed Web of Science ®Google Scholar
• Woodle MC, Scaria P. (2001). Cationic liposomes and nucleic acids. Curr Opin Colloid Interface Sci, 6, 78–84.
   Web of Science ®Google Scholar
• Yang Y, Li J, Liu F, Huang L. (2012). Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis. Mol Ther, 20, 609–615.
   PubMed Web of Science ®Google Scholar
• Zabner J. (1997). Cationic lipids used in gene transfer. Adv Drug Deliv Rev, 27, 17–28.
   PubMed Web of Science ®Google Scholar
• Zamore PD, Tuschl T, Sharp PA, Bartel DP. (2000). RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell, 101, 25–33.
   PubMed Web of Science ®Google Scholar
• Zhang S, Xu Y, Wang B, Qiao W, Liu D, Li Z. (2004). Cationic compounds used in lipoplexes and polyplexes for gene delivery. J Control Release, 100, 165–180.
   PubMed Web of Science ®Google Scholar
• Zhao YN, Zhi DF, Zhang SB. (2011). Cationic liposomes in different structural levels for gene delivery. In: Non-viral Gene Therapy. Yuan XB (Ed). Rijeka, Croatia: InTech, 293–318.
   Google Scholar
• Zhdanov RI, Podobed OV, Vlassov VV. (2002). Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy. Bioelectrochemistry, 58, 53–64.
   PubMed Web of Science ®Google Scholar
• Zimmermann TS, Lee AC, Akinc A, Bramlage B, Bumcrot D, Fedoruk MN, Harborth J, Heyes JA, Jeffs LB, John M, Judge AD, Lam K, McClintock K, Nechev LV, Palmer LR, Racie T, Röhl I, Seiffert S, Shanmugam S, Sood V, Soutschek J, Toudjarska I, Wheat AJ, Yaworski E, Zedalis W, Koteliansky V, Manoharan M, Vornlocher HP, MacLachlan I. (2006). RNAi-mediated gene silencing in non-human primates. Nature, 441, 111–114.
   PubMed Web of Science ®Google Scholar
• Zuhorn IS, Bakowsky U, Polushkin E, Visser WH, Stuart MC, Engberts JB, Hoekstra D. (2005). Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency. Mol Ther, 11, 801–810.
   PubMed Web of Science ®Google Scholar